Clinical Trial Update: The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial in Canada is evaluating maraviroc to augment rehabilitation outcomes after stroke and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: University of Calgary | Conditions: Stroke | Phase 2 | Status: RECRUITING